Philip Morris International reported strong first-quarter 2026 results, with earnings per share of $1.96 and a 9% year-over-year revenue increase, primarily driven by growth in smoke-free products like IQOS and ZYN. However, this growth is offset by declining sales of traditional combustible tobacco products. Despite these mixed trends, the company's stock trades at a significant price-to-earnings premium compared to its sector and historical averages, with a PEGY ratio of 2.14x, raising concerns about its current valuation. Investors should weigh the promising smoke-free product growth against the challenges in combustible sales and the stock's high valuation when considering Philip Morris for their portfolio.
